Methods for high-throughput (HTP) analysis of protein HighGlycan 13-10-2010 Pauline Rudd NIBRT glycosylation Scaffolds for alternative delivery SADEL 13-10-2010 ELAN Pharma Multi-modal effects of thyroid hormone replacement TRUST 13-10-2010 Patricia Kearney UCC for untreated older adults with subclinical hypothyroidism: a randomised placebo-controlled trial Translational Adolescent and Childhood Therapeutic TATICS 13-10-2010 John Cryan UCC Interventions in Compulsive Syndromes Epilepsy Pharmacogenomics: delivering biomarkers EpiPGX 13-10-2010 Gianpiero Cavalleri RCSI for clinical use Advanced Immunisation Technologies ADITEC 10-11-2010 Ivan Coulter Sigmoid Pharma NCDs and their social determinants in Mediterranean RESCAP-MED 10-11-2010 Kathleen Bennett TCD partner countries: building sustainable research capacity for effective policy intervention Targeting novel Mechanisms of Resolution in TIMER 10-11-2010 Luke O’Neill TCD inflammation 2012 Results – Innovation 1 Improving the organisation of maternal health service OptiBIRTH Cecily Begley TCD delivery, and optimising childbirth, by increasing Coordinator vaginal birth after caesarean section (VBAC) through enhanced women-centred care. Improving the organisation of maternal health service OptiBIRTH Declan Devane NUI Galway delivery, and optimising childbirth, by increasing vaginal birth after caesarean section (VBAC) through enhanced women-centred care. Apoptosis Modelling for Treatment Decisions in APO-DECIDE Jochen Prehn RCSI Colorectal Cancer Coordinator Apoptosis Modelling for Treatment Decisions in APO-DECIDE Mairin Rafferty Oncomark Colorectal Cancer Apoptosis Modelling for Treatment Decisions in APO-DECIDE Ciaran Clissman Pintail Colorectal Cancer
Methods for high-throughput (HTP) analysis of protein glycosylation HighGlycan 13-10-2010 Pauline Rudd NIBRT Scaffolds for alternative delivery SADEL 13-10-2010 ELAN Pharma Multi-modal effects of thyroid hormone replacement for untreated older adults with subclinical hypothyroidism: a randomised placebo-controlled trial TRUST 13-10-2010 Patricia Kearney UCC Translational Adolescent and Childhood Therapeutic Interventions in Compulsive Syndromes TATICS 13-10-2010 John Cryan UCC Epilepsy Pharmacogenomics: delivering biomarkers for clinical use EpiPGX 13-10-2010 Gianpiero Cavalleri RCSI Advanced Immunisation Technologies ADITEC 10-11-2010 Ivan Coulter Sigmoid Pharma NCDs and their social determinants in Mediterranean partner countries: building sustainable research capacity for effective policy intervention RESCAP-MED 10-11-2010 Kathleen Bennett TCD Targeting novel Mechanisms of Resolution in inflammation TIMER 10-11-2010 Luke O’Neill TCD 2012 Results – Innovation 1 Improving the organisation of maternal health service delivery, and optimising childbirth, by increasing vaginal birth after caesarean section (VBAC) through enhanced women-centred care. OptiBIRTH Cecily Begley Coordinator TCD Improving the organisation of maternal health service delivery, and optimising childbirth, by increasing vaginal birth after caesarean section (VBAC) through enhanced women-centred care. OptiBIRTH Declan Devane NUI Galway Apoptosis Modelling for Treatment Decisions in Colorectal Cancer APO-DECIDE Jochen Prehn Coordinator RCSI Apoptosis Modelling for Treatment Decisions in Colorectal Cancer APO-DECIDE Mairin Rafferty Oncomark Apoptosis Modelling for Treatment Decisions in Colorectal Cancer APO-DECIDE Ciaran Clissman Pintail